Sotera Health Services, LLC

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry. Headquartered in Broadview Heights, Ohio, United States, the company operates with the mission of "Safeguarding Global Health®" by ensuring medical products are safe for patients through essential sterilization and testing services.

The company's operations are primarily conducted through its three key businesses: Sterigenics®, Nordion®, and Nelson Labs®. Sterigenics provides outsourced terminal sterilization and irradiation services utilizing technologies such as gamma, ethylene oxide (EO), electron beam (E-beam), and X-ray. Nelson Labs offers extensive microbiological and analytical chemistry testing and advisory services, encompassing over 900 laboratory tests. Nordion is a crucial supplier of Cobalt-60, a radioisotope vital for gamma sterilization, and other medical isotopes. These services cater to a broad range of market segments, including the medical device, pharmaceutical, tissue, and food industries.

Led by Chairman and CEO Michael B. Petras Jr., Sotera Health maintains a significant global market position, serving approximately 5,000 customers across more than 50 countries, including a substantial portion of the top medical device and pharmaceutical companies. The company recently announced its Q1 2026 earnings release date and appointed Kenneth D. Krause to its Board of Directors in March 2026. In February 2026, Sotera Health reported its 20th consecutive year of revenue growth and provided its 2026 outlook. The company also saw a securities fraud class action dismissed in its favor in March 2025, a decision affirmed in February 2026, following a $408 million settlement of EO litigation in Illinois in 2023.